This inventor holds 1 USPTO granted patent. Top assignee: Debiopharm S.a.. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Amaud Hamel: Innovator in Medicinal Chemistry
Introduction
Amaud Hamel is a notable inventor based in Lausanne, Switzerland. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on pro-drugs.
Latest Patents
Amaud Hamel holds a patent for "Cyclic undecapeptide pro-drugs and uses thereof." This pro-drug comprises a cyclic undecapeptide with at least one amino acid residue, which is useful as a medicinal product. It has potential applications in the treatment of various pathological conditions of the eye. He has 1 patent to his name.
Career Highlights
Hamel is currently employed at Debiopharm S.A., a company known for its focus on developing innovative cancer therapies and other medical solutions. His work at Debiopharm has allowed him to further explore the applications of his inventions in real-world medical scenarios.
Collaborations
Throughout his career, Amaud has collaborated with esteemed colleagues, including Roland M Wenger and Manfred Mutter. These partnerships have enriched his research and contributed to the advancement of medicinal chemistry.
Conclusion
Amaud Hamel's contributions to the field of medicinal chemistry, particularly through his patent on cyclic undecapeptide pro-drugs, highlight his innovative spirit and dedication to improving medical treatments. His work continues to inspire advancements in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile